What is ARTEROLANE used for?

ARTEROLANE is indicated for Falciparum malaria.

What development phase is ARTEROLANE in?

ARTEROLANE is FDA-approved (marketed).

Last reviewed 2026-04-20 · How we verify

ARTEROLANE

FDA-approved active Small molecule Quality 10/100

At a glance

Generic name	ARTEROLANE
Modality	Small molecule
Therapeutic area	Rare Disease
Phase	FDA-approved

Approved indications

Falciparum malaria

Common side effects

No common side effects on file.

Key clinical trials

Comparison of Arterolane-piperaquine Versus Arterolane-piperaquine+Mefloquine Versus Artemether-lumefantrine in Kenyan Children (PHASE3)
Arterolane-PQP Versus DHA-PQP in Uncomplicated Falciparum Malaria in Eastern Myanmar (PHASE2,PHASE3)
RBx11160 Phase II Dose Ranging Study RBx/MMV05-06 (PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

ARTEROLANE CI brief — competitive landscape report
ARTEROLANE updates RSS · CI watch RSS